Publisher
Springer Science and Business Media LLC
Reference4 articles.
1. Zhang H, Zheng J, Hu N, Liu Y, Yang G, Liu M, et al. The status of nuclear medicine in China: the first official national survey. Eur J Nucl Med Mol Imaging. 2024;51(8):2172–8. https://doi.org/10.1007/s00259-024-06687-w.
2. National Health Commission of the People’s Republic of China. WS 817–2023: Standard for testing of quality control in positron emission tomographs (PET). People’s Repub China Heal Ind Stand. 2023. http://www.nhc.gov.cn/fzs/s7852d/202303/268dc736f5e6467bb30cecc9caf83606/files/38dfbe05f 7984f62bb9e6aa394241f4b.pdf.
3. Lan X, Huo L, Li S, Wang J, Cai W. State-of-the-art of nuclear medicine and molecular imaging in China: after the first 66 years (1956–2022). Eur J Nucl Med Mol Imaging. 2022;49(8):2455–61. https://doi.org/10.1007/s00259-022-05856-z.
4. Xia X, Qin C, Li M, Lan X. Standardized nuclear medicine residency training program in China. Eur J Nucl Med Mol Imaging. 2024. https://doi.org/10.1007/s00259-024-06798-4.